您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览25

S100B and its scavenger, soluble receptor for advanced glycation end products (sRAGE), participate in various acute and chronic brain disorders. However, their impact on hemorrhage-prone small vessel disease represented by cerebral microbleeds (CMBs) is unclear. The purpose of this study was to investigate the relationship of CMBs with plasma S100B and sRAGE.A cohort of 147 consecutive patients with first-ever acute lacunar stroke was prospectively enrolled. We collected demographic, clinical, and laboratory data, including plasma levels of S100B and sRAGE, and presence and number of CMBs using susceptibility-weighted imaging (SWI). Associations between plasma S100B, sRAGE levels and the presence, number, and location of CMBs were determined.CMBs were present in 58 patients (39.5

作者:Lulu, Xiao;Wen, Sun;Wenya, Lan;Yunyun, Xiong;Zuowei, Duan;Zongjun, Zhang;Wenping, Fan;Lili, Xu;Xia, Xie;Nan, Ma;Ruidong, Ye;Gelin, Xu;Xinfeng, Liu;Wusheng, Zhu

来源:Journal of the neurological sciences 2014 年 340卷 1-2期

相似文献
知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:25
作者:
Lulu, Xiao;Wen, Sun;Wenya, Lan;Yunyun, Xiong;Zuowei, Duan;Zongjun, Zhang;Wenping, Fan;Lili, Xu;Xia, Xie;Nan, Ma;Ruidong, Ye;Gelin, Xu;Xinfeng, Liu;Wusheng, Zhu
来源:
Journal of the neurological sciences 2014 年 340卷 1-2期
标签:
Cerebral microbleeds Lacunar stroke S100B Small vessel disease Susceptibility-weighted imaging sRAGE
S100B and its scavenger, soluble receptor for advanced glycation end products (sRAGE), participate in various acute and chronic brain disorders. However, their impact on hemorrhage-prone small vessel disease represented by cerebral microbleeds (CMBs) is unclear. The purpose of this study was to investigate the relationship of CMBs with plasma S100B and sRAGE.A cohort of 147 consecutive patients with first-ever acute lacunar stroke was prospectively enrolled. We collected demographic, clinical, and laboratory data, including plasma levels of S100B and sRAGE, and presence and number of CMBs using susceptibility-weighted imaging (SWI). Associations between plasma S100B, sRAGE levels and the presence, number, and location of CMBs were determined.CMBs were present in 58 patients (39.5